San Diego’s life sciences community could see its first initial public offering materialize this year or early next, signaling renewed hope in a recessionary market that had all but lost its appetite for risk-laden biotechs...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99